Cargando…
Research Progress of Exosome-Loaded miRNA in Osteosarcoma
Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of osteosarcoma, the treatment of osteosarcoma has many shortcomings, and its treatment is limited. MiRNAs and exosomes can be used as di...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859673/ https://www.ncbi.nlm.nih.gov/pubmed/35179996 http://dx.doi.org/10.1177/10732748221076683 |
_version_ | 1784654514487296000 |
---|---|
author | Yao, Peng Lu, Yubao Cai, Zongyan Yu, Tianci Kang, Yuchen Zhang, Yu Wang, Xulong |
author_facet | Yao, Peng Lu, Yubao Cai, Zongyan Yu, Tianci Kang, Yuchen Zhang, Yu Wang, Xulong |
author_sort | Yao, Peng |
collection | PubMed |
description | Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of osteosarcoma, the treatment of osteosarcoma has many shortcomings, and its treatment is limited. MiRNAs and exosomes can be used as diagnostic tools, and they play an important role in the occurrence and chemotherapy resistance of osteosarcoma. Therefore, providing a new method for the treatment of osteosarcoma is the key to solving this problem. To systematically summarize the research status of exoskeleton drug-loaded miRNA in osteosarcoma, we identified and evaluated 208 studies and found that exosome-carrying miRNA can be used as an index for the diagnosis and prognosis of osteosarcoma and share a certain relationship with chemosensitivity. In addition, exosomes can also be used as a carrier of genetic drugs able to regulate the progression of osteosarcoma. Based on the above findings, we propose suggestions for the future development of this field, aiming to bring new ideas for the early diagnosis and treatment of osteosarcoma. |
format | Online Article Text |
id | pubmed-8859673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-88596732022-02-22 Research Progress of Exosome-Loaded miRNA in Osteosarcoma Yao, Peng Lu, Yubao Cai, Zongyan Yu, Tianci Kang, Yuchen Zhang, Yu Wang, Xulong Cancer Control Review Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of osteosarcoma, the treatment of osteosarcoma has many shortcomings, and its treatment is limited. MiRNAs and exosomes can be used as diagnostic tools, and they play an important role in the occurrence and chemotherapy resistance of osteosarcoma. Therefore, providing a new method for the treatment of osteosarcoma is the key to solving this problem. To systematically summarize the research status of exoskeleton drug-loaded miRNA in osteosarcoma, we identified and evaluated 208 studies and found that exosome-carrying miRNA can be used as an index for the diagnosis and prognosis of osteosarcoma and share a certain relationship with chemosensitivity. In addition, exosomes can also be used as a carrier of genetic drugs able to regulate the progression of osteosarcoma. Based on the above findings, we propose suggestions for the future development of this field, aiming to bring new ideas for the early diagnosis and treatment of osteosarcoma. SAGE Publications 2022-02-18 /pmc/articles/PMC8859673/ /pubmed/35179996 http://dx.doi.org/10.1177/10732748221076683 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Yao, Peng Lu, Yubao Cai, Zongyan Yu, Tianci Kang, Yuchen Zhang, Yu Wang, Xulong Research Progress of Exosome-Loaded miRNA in Osteosarcoma |
title | Research Progress of Exosome-Loaded miRNA in Osteosarcoma |
title_full | Research Progress of Exosome-Loaded miRNA in Osteosarcoma |
title_fullStr | Research Progress of Exosome-Loaded miRNA in Osteosarcoma |
title_full_unstemmed | Research Progress of Exosome-Loaded miRNA in Osteosarcoma |
title_short | Research Progress of Exosome-Loaded miRNA in Osteosarcoma |
title_sort | research progress of exosome-loaded mirna in osteosarcoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859673/ https://www.ncbi.nlm.nih.gov/pubmed/35179996 http://dx.doi.org/10.1177/10732748221076683 |
work_keys_str_mv | AT yaopeng researchprogressofexosomeloadedmirnainosteosarcoma AT luyubao researchprogressofexosomeloadedmirnainosteosarcoma AT caizongyan researchprogressofexosomeloadedmirnainosteosarcoma AT yutianci researchprogressofexosomeloadedmirnainosteosarcoma AT kangyuchen researchprogressofexosomeloadedmirnainosteosarcoma AT zhangyu researchprogressofexosomeloadedmirnainosteosarcoma AT wangxulong researchprogressofexosomeloadedmirnainosteosarcoma |